Now with some rapid covid test, really hitting us with all kinds of wild news. Graphene masks still awaiting health canada approval and the human trials for the graphene pharma play is starting in august targeting C. Diff
Anyway this news still needs: Test requires final Health Canada and FDA approval
So its not a slam dunk yet and idk how much revs would actually come from this.
I got 10k shares last October at 1.04 and another 10k + 5k warrants restricted until august from the last PP at 2.5
These "split" pumps are amazing. Enjoy being the next AAPL whenever this run ends and eventually dropping violently from the peak and/or doing nothing for an extended stretch, people buying NVDA at 750. What I don't know greatly exceeds what I know but I'll be pretty surprised if NVDA is even at a higher price (after split adjustment) a year from today.
Just when I build a nice position in gold the market rotates back to risk on growth
Ha, I also got in gold, around spot 1855. I was going to use a stop just below 1825 but obviously the market went from like 1830 at close yesterday to 1775 or something by open today (going off top of head). Rekt. My position goes out to August and September, guess I’m going to sit on it and give it some time now. I’m in mostly GLD 185 calls.
somedays it does feel like I'm just repeatedly banging my head against the wall... TS was right I'm eating ***** on KNR
Still the entire allocation to penny stocks is under 5% in my overall portfolio. I have more $ in Accenture than all of the penny stocks I've talked about.
Again this is a trading thread though and last time I mentioned zen was halted it moved from around 1.90 to 3.77
Any thoughts on CAT as a +EV swing trade. The current 1year RSI is 22 which makes it seem to me like a slam dunk swing trade with a hold period of say 1-3 months.
Market conditions seem to be declining however and I feel construction will be hit hard if the market frazzles over the impending rate increases coming down the road. Thoughts?
Is it time to get back into WFC? I'm thinking getting in between 38-40 could well be a nice play, unless we're in the start of some kind of dotcom bubble market collapse.
Now with some rapid covid test, really hitting us with all kinds of wild news. Graphene masks still awaiting health canada approval and the human trials for the graphene pharma play is starting in august targeting C. Diff
Anyway this news still needs: Test requires final Health Canada and FDA approval
So its not a slam dunk yet and idk how much revs would actually come from this.
I got 10k shares last October at 1.04 and another 10k + 5k warrants restricted until august from the last PP at 2.5
The **** bro? Getting frauded out by one OTC Canadian company making a "instant covid air sniffer" wasn't enough for you? You need to go find a second Canadian covid fraud OTC company - this time with graphene (I'm loling) and put your money in? This one is an even less clever fraud than the last one.
Ride the pump wave if you want - that may well be +EV - but recognize that you're longing a pump fraud and get out as soon as it turns.
Sunday night futures forecast for the week ahead: MORE PAIN
So you aren't making an actual prediction—just your usual vague impending doom noise. Just wanted to give you a chance to say something concrete. But maybe you've learned your lesson to remain as vague as possible after the 'millions of Americans dead this winter' letter.
So you aren't making an actual prediction—just your usual vague impending doom noise. Just wanted to give you a chance to say something concrete. But maybe you've learned your lesson to remain as vague as possible after the 'millions of Americans dead this winter' letter.
Anyone else like CLX here? It's now given up almost all of its pandemic boost and it's just above former resistance, which if the market doesn't collapse seem like it should be support. Seems like a pretty solid play to me and I started building a position today around 173.
Another thing I find very interesting about Field Trip Health is they are in the process of developing a psilocybin derivative that only lasts 2-3 hours. This is patentable.
I'm not sure what my personal experience would have to do with overall social stigma and acceptance, but yes, I've done my share of dabbling.
People are way way way more polarized on hallucinogenics vs marijuana. That is a whole different wall to break down. And yes, I'm aware of the extremely positive research results around things like PTSD. Thats been going on for a good 20 years
in fairness, anyone who's read more than 5 of shuffle's posts should know not to listen to his doomsayings by now
thoughts on NLS (Nautilus)? their subscriber model is supposed to have 250k members by the end of the year, 2m by 2026 -- so let's say they get 1m by 2024. $20/month, that's $240m in new revenue from SaaS, which has an absurd profit.
NLS total revenue, boosted by COVID obviously, in 2020 was 550m. This is a huge potential recurring revenue source, and the stock is still trading at a 6 P/E, 400m EV.
Seems like a decent bet, the obvious drawback is they fail to execute on their subscription platform, #s miss, and it either folds or grows more slowly than projected.
